← Back to All US Stocks

AYRWF Stock Analysis - Ayr Wellness Inc. AI Rating

AYRWF OTC Medicinal Chemicals & Botanical Products A1 CIK: 0001847462
Recently Updated • Analysis: Mar 20, 2026 • SEC Data: 2026-03-20
AI Rating
HOLD
5% Confidence

📊 AYRWF Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: N/A
Current Ratio: N/A
Debt/Equity: N/A
EPS: $0.00
AI Rating: HOLD with 5% confidence

Investment Thesis

Insufficient financial data available to conduct meaningful fundamental analysis. The company's SEC filings lack essential income statement, balance sheet, and cash flow metrics required for proper evaluation. Unable to assess profitability trends, financial health, or growth quality due to data unavailability.

AYRWF Strengths

  • + Company filed with SEC (CIK registered)
  • + Operates in medicinal chemicals sector
  • + No recent insider selling detected (0 Form 4 filings in 90 days)

AYRWF Risks

  • ! Complete absence of revenue and profitability data
  • ! No balance sheet metrics available (assets, equity, debt)
  • ! Impossible to assess liquidity, solvency, or operational cash flow
  • ! Only 1 metric available out of required fundamental data set
  • ! Unable to determine financial viability or operational performance

Key Metrics to Watch

AYRWF Financial Metrics

Revenue
N/A
Net Income
N/A
EPS (Diluted)
$0.00
Free Cash Flow
N/A
Total Assets
N/A
Cash Position
N/A

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

AYRWF Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA N/A
FCF Margin N/A

AYRWF vs Default Sector

How Ayr Wellness Inc. compares to Default sector averages

Net Margin
AYRWF 0.0%
vs
Sector Avg 12.0%
AYRWF Sector
ROE
AYRWF 0.0%
vs
Sector Avg 15.0%
AYRWF Sector
Current Ratio
AYRWF 0.0x
vs
Sector Avg 1.8x
AYRWF Sector
Debt/Equity
AYRWF 0.0x
vs
Sector Avg 0.7x
AYRWF Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

AYRWF Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
N/A
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A

AYRWF Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

AYRWF SEC Filings

Access official SEC EDGAR filings for Ayr Wellness Inc. (CIK: 0001847462)

📋 Recent SEC Filings

Date Form Document Action
Apr 25, 2024 SC 13G d752536dsc13g.htm View →
Feb 14, 2023 SC 13G brhc10047757_sc13g.htm View →
Mar 24, 2021 SC 13G ayrwf_32421.htm View →

Frequently Asked Questions about AYRWF

What is the AI rating for AYRWF?

Ayr Wellness Inc. (AYRWF) has an AI rating of HOLD with 5% confidence, based on fundamental analysis of SEC EDGAR filings.

What are AYRWF's key strengths?

Company filed with SEC (CIK registered). Operates in medicinal chemicals sector.

What are the risks of investing in AYRWF?

Complete absence of revenue and profitability data. No balance sheet metrics available (assets, equity, debt).

What is AYRWF's revenue and growth?

Ayr Wellness Inc. reported revenue of N/A.

Does AYRWF pay dividends?

Ayr Wellness Inc. does not currently pay dividends.

Where can I find AYRWF SEC filings?

Official SEC filings for Ayr Wellness Inc. (CIK: 0001847462) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is AYRWF's EPS?

Ayr Wellness Inc. has a diluted EPS of $0.00.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 20, 2026 | Data as of: 2026-03-20 | Powered by Claude AI